Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Buffer Preparation for Purification Steps – V 2.0

Posted on By


Biosimilars: SOP for Buffer Preparation for Purification Steps – V 2.0


Standard Operating Procedure for Buffer Preparation for Purification Steps in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/176/2025
Supersedes SOP/BS/176/2022
Page No. Page 1 of 10
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for the GMP-compliant preparation, filtration, labeling, and storage of buffers used in downstream purification of biosimilar products including chromatography, viral filtration, and final formulation steps.

2. Scope

This SOP is applicable to all buffer solutions prepared within the biosimilar downstream process area for use in affinity, ion-exchange, hydrophobic interaction, SEC, and viral clearance steps.

3. Responsibilities

  • Production: Prepare and filter buffers as per approved Buffer Preparation Sheets (BPS), record all entries in buffer logbook.
  • QA: Verify pH, conductivity, labeling, and review all documentation.
  • QC: Perform analytical release testing if required (e.g., microbial load, endotoxin).

4. Accountability

The Downstream Manufacturing Lead is accountable for ensuring the use of properly prepared and verified buffers in each batch operation.

5. Procedure

5.1 Pre-Preparation Checks

  1. Verify that the buffer preparation tank, mixer, and pH/conductivity meters are cleaned and calibrated.
  2. Ensure availability of approved Buffer Preparation Sheet (Annexure-1) and relevant MSDS documents.
  3. Confirm material batch numbers and expiry dates for all buffer components.

5.2 Buffer Preparation Steps

  1. Fill the preparation tank with pre-measured WFI or purified water as specified in the BPS.
  2. Add buffer salts, acids, or bases in sequence under slow agitation using sanitized scoops or transfer lines.
  3. Adjust pH to the specified value using 1 M NaOH or 1 M HCl as required.
  4. Verify final conductivity and pH using calibrated meters and record results in Annexure-2.

5.3 Filtration and Transfer

  1. Filter the buffer solution using 0.22 µm or 0.45 µm filters depending on usage (virus filtration/formulation vs general chromatography).
  2. Transfer the filtered buffer into labeled stainless steel or single-use storage containers.
  3. Attach tamper-evident seals post-filtration.

5.4 Labeling and Storage

  1. Label the buffer container with the following:
    • Buffer Name
    • Batch No.
    • Date of Preparation
    • Prepared By
    • Expiry Date (as per BPS)
  2. Store the buffer at the designated temperature (typically 2–8°C or room temperature) per stability data.

5.5 Documentation

  1. Complete the Buffer Logbook entry with all preparation and filter details.
  2. Attach filter integrity certificate if applicable.

6. Abbreviations

  • BPS: Buffer Preparation Sheet
  • WFI: Water for Injection
  • pH: Potential of Hydrogen
  • MSDS: Material Safety Data Sheet

7. Documents

  1. Buffer Preparation Sheet – Annexure-1
  2. pH and Conductivity Record – Annexure-2

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • USP <1227> – Validation of Compendial Procedures
  • WHO TRS 999 – GMP for Biotherapeutic Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Buffer Preparation Sheet

Buffer Name Components Target pH Conductivity (mS/cm) Volume (L) Expiry
Phosphate Buffer KH₂PO₄, Na₂HPO₄ 7.0 10.5 50 05/05/2025

Annexure-2: pH and Conductivity Record

Date Buffer Name pH Conductivity Tested By
04/05/2025 Phosphate Buffer 7.0 10.6 mS/cm Sunita Reddy

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Integrated filtration and labeling instructions with annexures Process harmonization
See also  Biosimilars: SOP for Use of Single-Use Systems in DSP - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Understanding Read-and-Understand Training vs Practical Demonstration
Next Post: Elixir Department: SOP for Rinsing Procedure Using Purified Water – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version